Real-time enrollment status for this prostate cancer (adenocarcinoma) clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 8:35 PM UTC
| NCT Number | NCT06801236 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer (Adenocarcinoma) |
| Phase | PHASE1 |
| Target Enrollment | 88 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Acerand Therapeutics (Hong Kong) Limited |
| Last Updated on CT.gov | August 4, 2026 (3 weeks ago) |
As of August 27, 2026: Clinical trial NCT06801236 is currently recruiting participants. This phase1 study for prostate cancer (adenocarcinoma) is actively seeking new participants at 8 locations across the United States. The study is sponsored by Acerand Therapeutics (Hong Kong) Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06801236 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06801236 was last updated 3 weeks ago (August 4, 2026). HelloStudys verifies this status automatically.